Metsera
Metsera offers oral and injectable incretin, non-incretin and combination therapies with potential profiles to address multiple therapeutic targets, enabling users to meet the future needs of a rapidly evolving weight loss treatment landscape.
$290M
Latest Funding
Series A
Latest Funding Stage
2024-04-18
Funding Date
14
Employees
United States
Location
New York, New York
City & State
Sales-Ready Summary
Metsera recently raised a $290M Series A and utilizes a tech stack including CDN and video players, making them a high-intent prospect for vendors in those categories. Reach out to their technology leadership to discuss scaling their infrastructure.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Charta Health
Charta Health is an AI-powered platform that optimizes medical billing and coding workflows. Each chart undergoes a pre-bill review, which helps Charta Health find missed coding opportunities, avoid claim denials, and guarantee billing standards are followed.